1
|
Tachibana H, Daino K, Ishikawa A, Morioka T, Shang Y, Ogawa M, Matsuura A, Shimada Y, Kakinuma S. Genomic profile of radiation-induced early-onset mouse B-cell lymphoma recapitulates features of Philadelphia chromosome-like acute lymphoblastic leukemia in humans. Carcinogenesis 2022; 43:693-703. [PMID: 35395675 DOI: 10.1093/carcin/bgac034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2022] [Revised: 03/22/2022] [Accepted: 04/04/2022] [Indexed: 11/12/2022] Open
Abstract
Epidemiological studies have revealed a radiation-related increase in the risk of developing acute lymphoblastic leukemia (ALL). Our recent study revealed early induction and increased risk of precursor B-cell (pB) lymphomas in mice after radiation exposure. However, the genomic landscape of radiation-induced B-cell lymphomas remains unclear. To identify the relevant genetic alterations in mice, whole-exome sequencing was performed on both early-onset and late-onset B-cell lymphomas that developed spontaneously or after gamma-irradiation. In addition to multiple driver mutations, the data revealed that interstitial deletion of chromosome 4, including Pax5, and missense mutations in Jak3 are unique genomic alterations in radiation-induced, early-onset B-cell lymphomas. RNA sequencing revealed a pB-cell-type gene-expression profile with no involvement of known fusion genes for human ALLs in the early-onset B-cell lymphomas. Activation of Jak3/Stat5 signaling in early-onset B-cell lymphomas was validated using western capillary electrophoresis. Those features were similar to those of Philadelphia chromosome-like ALL. Our data suggest a critical role for Pax5 loss-of-function mutations in initiating B-cell leukemogenesis coupled with activation of Jak3/Stat5 signaling as a basis for the rapid development of radiation-induced pB-ALL. These molecular signatures for radiation-induced cancers will inform both risk assessment and potential targeted therapies for pB-ALL.
Collapse
Affiliation(s)
- Hirotaka Tachibana
- Department of Radiation Effects Research, Quantum Medical Science Directorate, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology (QST); Chiba, Japan.,Department of Biology, Graduate School of Science, Chiba University; Chiba, Japan
| | - Kazuhiro Daino
- Department of Radiation Effects Research, Quantum Medical Science Directorate, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology (QST); Chiba, Japan
| | - Atsuko Ishikawa
- Department of Radiation Effects Research, Quantum Medical Science Directorate, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology (QST); Chiba, Japan
| | - Takamitsu Morioka
- Department of Radiation Effects Research, Quantum Medical Science Directorate, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology (QST); Chiba, Japan
| | - Yi Shang
- Department of Radiation Effects Research, Quantum Medical Science Directorate, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology (QST); Chiba, Japan
| | - Mari Ogawa
- Department of Radiation Effects Research, Quantum Medical Science Directorate, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology (QST); Chiba, Japan
| | - Akira Matsuura
- Department of Biology, Graduate School of Science, Chiba University; Chiba, Japan
| | - Yoshiya Shimada
- Department of Radiation Effects Research, Quantum Medical Science Directorate, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology (QST); Chiba, Japan.,Chief director, Institute for Environmental Sciences; Aomori, Japan
| | - Shizuko Kakinuma
- Department of Radiation Effects Research, Quantum Medical Science Directorate, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology (QST); Chiba, Japan
| |
Collapse
|
2
|
Genik PC, Vyazunova I, Steffen LS, Bacher JW, Bielefeldt-Ohmann H, McKercher S, Ullrich RL, Fallgren CM, Weil MM, Ray FA. Leukemogenesis in heterozygous PU.1 knockout mice. Radiat Res 2014; 182:310-5. [PMID: 25076114 DOI: 10.1667/rr13738.1] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Most murine radiation-induced acute myeloid leukemias involve biallelic inactivation of the PU.1 gene, with one allele being lost through a radiation-induced chromosomal deletion and the other allele affected by a recurrent point mutation in codon 235 that is likely to be spontaneous. The short latencies of acute myeloid leukemias occurring in nonirradiated mice engineered with PU.1 conditional knockout or knockdown alleles suggest that once both copies of PU.1 have been lost any other steps involved in leukemogenesis occur rapidly. Yet, spontaneous acute myeloid leukemias have not been reported in mice heterozygous for a PU.1 knockout allele, an observation that conflicts with the understanding that the PU.1 codon 235 mutation is spontaneous. Here we describe experiments that show that the lack of spontaneous leukemia in PU.1 heterozygous knockout mice is not due to insufficient monitoring times or mouse numbers or the genetic background of the knockout mice. The results reveal that spontaneous leukemias that develop in mice of the mixed 129S2/SvPas and C57BL/6 background of knockout mice arise by a pathway that does not involve biallelic PU.1 mutation. In addition, the latency of radiation-induced leukemia in PU.1 heterozygous mice on a genetic background susceptible to radiation-induced leukemia indicates that the codon 235 mutation is not a rate-limiting step in radiation leukemogenesis driven by PU.1 loss.
Collapse
Affiliation(s)
- Paula C Genik
- a Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, Colorado
| | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Haines J, Bacher J, Coster M, Huiskamp R, Meijne E, Mancuso M, Pazzaglia S, Bouffler S. Microsatellite instability in radiation-induced murine tumours; influence of tumour type and radiation quality. Int J Radiat Biol 2010; 86:555-68. [PMID: 20545567 DOI: 10.3109/09553001003734600] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
PURPOSE To investigate microsatellite instability (MSI) in radiation-induced murine tumours, its dependence on tissue (haemopoietic, intestinal, mammary, brain and skin) and radiation type. MATERIALS AND METHODS DNA from spontaneous, X-ray or neutron-induced mouse tumours were used in Polymerase Chain Reactions (PCR) with mono- or di-nucleotide repeat markers. Deviations from expected allele size caused by insertion/deletion events were assessed by capillary electrophoresis. RESULTS Tumours showing MSI increased from 16% in spontaneously arising tumours to 23% (P = 0.014) in X-ray-induced tumours and rising again to 83% (P << 0.001) in neutron-induced tumours. X-ray-induced Acute Myeloid Leukaemias (AML) had a higher level of mono-nucleotide instability (45%) than di-nucleotide instability (37%). Fifty percent of neutron-induced tumours were classified as MSI-high for mono-nucleotide markers and 10% for di-nucleotide markers. Distribution of MSI varied in the different tumour types and did not appear random. CONCLUSIONS Exposure to ionising radiation, especially neutrons, promotes the development of MSI in mouse tumours. MSI may therefore play a role in mouse radiation tumourigenesis, particularly following high Linear Energy Transfer (LET) exposures. MSI events, for a comparable panel of genome-wide markers in different tissue types, were not randomly distributed throughout the genome.
Collapse
Affiliation(s)
- Jackie Haines
- Health Protection Agency-Centre for Radiation, Chemical and Environmental Hazards, Chilton, Oxfordshire, UK.
| | | | | | | | | | | | | | | |
Collapse
|
4
|
Jawad M, Cole C, Zanker A, Lo P, Fitch S, Plumb M. Evidence for clustered tumour suppressor gene loci on mouse chromosomes 2 and 4 in radiation-induced acute myeloid leukaemia. Int J Radiat Biol 2006; 82:383-91. [PMID: 16846973 DOI: 10.1080/09553000600784161] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
PURPOSE To investigate the influence of genetic and epigenetic factors on allelic loss on chromosomes 2 and 4 in mouse radiation-induced acute myeloid leukaemia (r-AML). METHODS r-AML that arose in (CBA/HxC57BL/6)F1xCBA/H and F1xC57BL/6 mice were screened for transcription factor PU1 (also known as SPI-1) gene mutations and methylation of the paired box gene 5 (Pax5) gene promoter. We have increased the statistical significance of a genetic linkage analysis of affected F1xCBA/H mice to test for linkage to loci implicated directly or indirectly with r-AML-susceptibility. RESULTS There was a statistically significant difference ( p < 10-4) in the frequency of PU1 gene mutations in F1xCBA/H and F1xC57BL/6 r-AML, implicating a second linked but genotype-dependent myeloid leukaemia suppressor gene on chromosome 2. A suggestive CBA/H r-AML-resistance locus maps within 10 cM of the minimally deleted region on chromosome 4. The Pax5 gene promoter is subject to ongoing subclonal promoter methylation in the r-AML, evidence that Pax5 gene silencing confers a selective advantage during clonal expansion in vivo. CONCLUSIONS Allelic loss in mouse r-AML and subsequent tumour suppressor gene mutation (PU1) or silencing (Pax5) is strongly influenced by genetic background and/or epigenetic factors, and driven by in vivo clonal selection.
Collapse
MESH Headings
- Animals
- Base Sequence
- Bone and Bones/pathology
- Bone and Bones/radiation effects
- Chromosomes
- Cluster Analysis
- Electrophoresis, Polyacrylamide Gel
- Gene Silencing
- Genes, Tumor Suppressor/radiation effects
- Leukemia, Myeloid, Acute/etiology
- Leukemia, Myeloid, Acute/genetics
- Leukemia, Radiation-Induced/genetics
- Mice
- Mice, Inbred C57BL
- Mice, Inbred CBA
- Promoter Regions, Genetic
- Spleen/pathology
- Spleen/radiation effects
Collapse
Affiliation(s)
- Mays Jawad
- Department of Genetics, University of Leicester, Leicester, UK
| | | | | | | | | | | |
Collapse
|
5
|
Pulte D, Lopez RA, Baker ST, Ward M, Ritchie E, Richardson CA, O'Neill DW, Bank A. Ikaros increases normal apoptosis in adult erythroid cells. Am J Hematol 2006; 81:12-8. [PMID: 16369973 DOI: 10.1002/ajh.20507] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
Ikaros is a critical transcriptional regulator of hematopoietic cell differentiation. In addition to its effects on the lymphoid system and hematopoietic stem-cell compartment, we have previously shown that Ikaros is also required for normal erythroid development. In this report, we compare Ikaros-dependent gene expression in erythroid cells of mice lacking the Ikaros protein with that of normal mice in purified adult bone-marrow erythroid cells (BMRC). Gene expression, measured by Affymetrix microarray analysis, indicates that in the BMRC of Ikaros-null mice, there is significant up-regulation of SMADs 6 and 7, serine protease inhibitor 3, and immediate-early protein 3 (IER3), all proteins that play a modulating role in apoptosis. We investigate the role of Ikaros in oxidative stress-induced apoptosis using Annexin-V staining and FACS analysis. We find a decrease in apoptosis in the BMRC of Ikaros-null mice compared to normal mice. This effect is also seen in nonerythroid cells but is stronger in BMRC. We conclude that normal Ikaros function increases normal apoptosis in erythroid cells. The data also suggest that Ikaros plays a role in apoptosis-mediated events in other normal hematopoietic cell lineages.
Collapse
Affiliation(s)
- Dianne Pulte
- Department of Medicine, Columbia University, New York, NY, USA
| | | | | | | | | | | | | | | |
Collapse
|
6
|
Darakhshan F, Badie C, Moody J, Coster M, Finnon R, Finnon P, Edwards AA, Szluinska M, Skidmore CJ, Yoshida K, Ullrich R, Cox R, Bouffler SD. Evidence for complex multigenic inheritance of radiation AML susceptibility in mice revealed using a surrogate phenotypic assay. Carcinogenesis 2005; 27:311-8. [PMID: 16093251 DOI: 10.1093/carcin/bgi207] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023] Open
Abstract
The mapping of genes which affect individual cancer risk is an important but complex challenge. A surrogate assay of susceptibility to radiation-induced acute myeloid leukaemia (AML) in the mouse based on chromosomal radiosensitivity has been developed and validated. This assay was applied to the mapping of radiation-induced AML risk modifier loci by association with microsatellite markers. A region on chromosome (chr) 18 with strong association is identified and confirmed by backcross analysis. Additional loci on chrs 8 and 13 show significant association. A key candidate gene Rbbp8 on chr18 is identified. Rbbp8 is shown to be upregulated in response to X-irradiation in the AML sensitive CBA strain but not AML resistant C57BL/6 strain. This study demonstrates the strength of utilizing surrogate endpoints of cancer susceptibility in the mapping of mouse loci and identifies additional loci that may affect radiation cancer risk.
Collapse
Affiliation(s)
- F Darakhshan
- Radiation Effects Department, Health Protection Agency, Radiation Protection Division, Chilton, Didcot, Oxfordshire, OX11 0RQ, UK
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Bouffler S, Silver A, Cox R. Mechanistic and genetic studies of radiation tumorigenesis in the mouse--implications for low dose risk estimation. JOURNAL OF RADIOLOGICAL PROTECTION : OFFICIAL JOURNAL OF THE SOCIETY FOR RADIOLOGICAL PROTECTION 2002; 22:A11-A16. [PMID: 12400940 DOI: 10.1088/0952-4746/22/3a/302] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
Radiation cancer risk estimates remain firmly based upon epidemiological data. Experimental validation of the fundamental aspects of these risk estimates relies on animal studies. In particular, animal model systems for radiation carcinogenesis can provide data for mechanistic modelling approaches to risk estimation. The accuracy and validity of risk estimation models developed will depend upon the extent of our understanding of the process of radiation carcinogenesis. The study of 'spontaneous' tumours in humans continues to provide a sound context in which to consider the mechanisms of radiation carcinogenesis. Several mouse radiation carcinogenesis systems are considered here with particular reference to the nature of the initiating event and the influence of genetic susceptibility on radiation-induced cancer.
Collapse
Affiliation(s)
- Simon Bouffler
- National Radiological Protection Board, Chilton, Didcot, Oxfordshire, UK
| | | | | |
Collapse
|
8
|
Ban N, Yoshida K, Aizawa S, Wada S, Kai M. Cytogenetic analysis of radiation-induced leukemia in Trp53-deficient C3H/He mice. Radiat Res 2002; 158:69-77. [PMID: 12071805 DOI: 10.1667/0033-7587(2002)158[0069:caoril]2.0.co;2] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
C3H/He mice develop acute myeloid leukemia (AML) after whole-body irradiation, but the strain becomes highly susceptible to stem cell leukemia (SCL) when a null mutation is introduced into the Trp53 gene. To examine the etiology of SCL and the influence of chromosomal instability on leukemogenesis, 12 SCLs and two AMLs arising from Trp53-deficient C3H/He mice were investigated cytogenetically. Each SCL demonstrated cell-to-cell variation in the number and structural integrity of their chromosomes, indicating chromosomal instability. Typical deletion of chromosome 2 was observed in the two AML cases, while most SCL cells did not display this aberration. Deletions and rearrangements of chromosome 11 were noticeable in SCLs from Trp53 heterozygotes but not in AMLs. Analysis of loss of heterozygosity revealed that aberrations involving chromosome 11 in SCLs resulted in loss of the wild-type Trp53 allele. These results suggest that loss of Trp53 function triggers the tumorigenic process leading toward SCL through the induction of chromosomal instability, and that SCL and AML are distinct varieties of leukemia.
Collapse
Affiliation(s)
- Nobuhiko Ban
- Oita University of Nursing and Health Sciences, 2944-9 Megusuno, Notsuharu, Oita-gun, Oita 870-1201, Japan.
| | | | | | | | | |
Collapse
|